À propos de CARE™

Le Comité académique de CARE™ célèbrera sa 15e année en 2020 et entend poursuivre le débat en cours sur les biosimilaires et l’accès à l’innovation à l’aide d’un programme robuste en 2020 et au-delà.

Le Comité académique de CARE™ (Community. Academic. Research. Education.) est un groupe d’éminents spécialistes et de fournisseurs de soins de santé connexes de partout au Canada.

Nous élaborons des initiatives de formation destinées à nos pairs, aux infirmières, aux pharmaciens, aux patients, au gouvernement ainsi qu’aux payeurs du secteur privé.

SAVOIR PLUS

Événements actuels

Publications [récentes]

CARE™ at ASH happened on December 6th, 2019. It is the largest gathering of hematologists outside of Canada. CARE™ has provided a summary report and the speaker slides presentations.

Voir la publication

Hematology

CARE™ at ASH 2019:

Presentations & Report

Rheumatology

CARE™ Perspectives:

More Innovation Needed in Rheumatology

Select members of the CARE™ Rheumatology Faculty used the 2019 ACR conference as an opportunity to meet and discuss the impact of, and continued support for access to innovation and biosimilar adoption, specifically from a Canadian context/perspective.

Voir la publication

The CARE™ ACG/UEGW 2019 Conference Report highlights key news in gastroenterology with a specific focus on inflammatory bowel disease (IBD), framed from a Canadian perspective.

Voir la publication

Gastroenterology

CARE™ Perspectives:

ACG/UEGW 2019

Genitourinary

CARE™ Perspectives:

ESMO 2019

2018 and 2019 have seen numerous data updates and news that could affect the management of prostate cancer (PC) in Canada. The following CARE™ Conference Report from ESMO 2019 focuses on prostate cancer updates.

Voir la publication

Publications actuels

Twitter

#DDW Report is online! Covering news and developments in UC and CD informed abstracts from #DDW2020. Dr. John Marshall, CARE™ Faculty reviews treatment options and considers impact within the context of Canadian #healthcare https://careeducation.ca/reports/care-perspectives-ddw-report/ @marshllj

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30848-5/fulltext#.XvOq3pN50CM.twitter

Load More...

Ressources

Forum on Complement Case Series

This 4-part series sheds light on challenges many Paroxysmal Nocturnal Hemoglobinuria (PNH) patients encounter during their disease course.